Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Advexin plus chemotherapy effective against head and neck cancer cells

Nov. 10, 2004

Aventis terminates Genasense agreements with Genta

Nov. 10, 2004

IDM, Walter Reed Army Institute of Research sign cancer vaccine agreement

Nov. 10, 2004

Peplin to raise funds to support phase II studies of PEP-005 Topical

Nov. 10, 2004

Indian researchers isolate new cytotoxic terpenes from plants

Nov. 9, 2004

Affimed Therapeutics and Syngenta to codevelop Tandab antibody

Nov. 9, 2004

Marqibo submitted for marketing approval in Canada

Nov. 9, 2004

GX-015-070 enters phase I

Nov. 9, 2004

Phase II trials in Canada, E.U. evaluate AMD-3100 for stem cell transplantation

Nov. 9, 2004

Phenoxodiol receives fast track status for recurrent ovarian cancer

Nov. 9, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...